ooops my bad.....I'm with you on P if it works in Phase2. OM trial has a ways to go...Looks like about 20 patients dosed as of Biotech conference....But who knows what's going on in Leo's mind. He sure does have a lot of choices to make a deal on....I just hope he doesn't choose Aspire.
